| Identification | Back Directory | [Name]
1H-Indazole-3-carboxamide, N-[(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-1-butyl- | [CAS]
2682867-55-4 | [Synonyms]
ADB-BUTINACA (exempt preparation)
1H-Indazole-3-carboxamide, N-[(1S)-1-(aminocarbonyl)-2,2-dimethylpropyl]-1-butyl- | [Molecular Formula]
C18H26N4O2 | [MOL File]
2682867-55-4.mol | [Molecular Weight]
330.42 |
| Chemical Properties | Back Directory | [Boiling point ]
583.4±30.0 °C(Predicted) | [density ]
1.18±0.1 g/cm3(Predicted) | [solubility ]
DMF: 20 mg/ml
DMSO: 5 mg/ml
Ethanol: 20 mg/ml | [pka]
11.44±0.46(Predicted) |
| Hazard Information | Back Directory | [Description]
ADB-BUTINACA (Item No. 29350) is an analytical reference standard that is structurally similar to known synthetic cannabinoids. This product is intended for research and forensic applications. | [References]
[1] SPARKES E, CAIRNS E A, KEVIN R C, et al. Structure–activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA?[J]. MedChemComm, 2021, 2: 156-174. DOI: 10.1039/d1md00242b
[2] ROBERT KRONSTRAND. The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons[J]. Drug Testing and Analysis, 2021, 14 4: 634-652. DOI: 10.1002/dta.3203 |
|
|